MONTVALE, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) today announced that David Lowe, Ph.D., Chief Scientific
Officer, will provide a company update at the ThinkEquity Partners LLC An
Educational Forum for Healthcare on Thursday, October 4, 2007 at 2:10 p.m.
(EDT). The conference is being held at The Pierre Hotel in New York City.
Interested parties may access the live webcast of the presentation by
visiting the "Investors" section of Memory Pharmaceuticals' website at
http://www.memorypharma.com . Archived versions of the webcast will be
available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com .
SOURCE Memory Pharmaceuticals Corp.
-0- 09/27/2007
/CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249; or Laura
Perry of Stern Investor Relations, Inc., +1-212-362-1200, both for Memory
Pharmaceuticals Corp./
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.; ThinkEquity Partners LLC An Educational
Forum for Healthcare
ST: New Jersey, New York
IN: BIO MTC HEA
SU: TDS CCA
LL-BS
-- NYTH025 --
7684 09/27/2007 08:00 EDT http://www.prnewswire.com
